Arcturus Therapeutics
ARCT
113 hedge funds and large institutions have $379M invested in Arcturus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 36 reducing their positions, and 20 closing their positions.
123% more call options, than puts
Call options by funds: $6.67M | Put options by funds: $2.99M
16% more capital invested
Capital invested by funds: $328M → $379M (+$51.2M)
2.06% more ownership
Funds ownership: 83.4% → 85.46% (+2.1%)
6% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 36
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
3% less funds holding
Funds holding: 116 → 113 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$11.7M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$10.1M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.79M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.64M |
| 2 |
State Street
Boston,
Massachusetts
|
-$8.24M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$2.95M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.18M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$1.93M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EMG
126
ETF Managers Group
Summit,
New Jersey
| – | -$116K | -7,843 | Closed |
|
|
SO
127
STRS Ohio
Columbus,
Ohio
| – | -$63K | -4,300 | Closed |
|
|
HNWAG
128
High Net Worth Advisory Group
Naples,
Florida
| – | -$22K | -1,500 | Closed |
|
|
LFG
129
Larson Financial Group
St Louis,
Missouri
| – | -$5K | -340 | Closed |
|
130
First Manhattan
New York
| – | -$2K | -200 | Closed |
|
|
PA
131
Parallel Advisors
San Francisco,
California
| – | -$296 | -17 | Closed |
|
|
NA
132
NewEdge Advisors
New Orleans,
Louisiana
| – | +$453 | +26 | New |
|
ARCT Hedge Fund Activity: Q4 2022 in Review
113 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q4 2022, worth a combined $379M — up 16% from $328M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ARCT and 19 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 38 added.
The largest buyer was Federated Hermes, adding an estimated $11.7M. The largest seller was Point72 Asset Management, cutting an estimated $9.64M.
- 113 institutional investors held Arcturus Therapeutics (ARCT) as of Q4 2022, down from 116 in Q3 2022.
- Funds reported $379M of Arcturus Therapeutics stock for Q4 2022, up 16% quarter-over-quarter.
- 19 funds opened new Arcturus Therapeutics positions in Q4 2022 and 20 closed out, a net change of -1 holder.
- The largest Arcturus Therapeutics buyer in Q4 2022 was Federated Hermes, an estimated $11.7M added.
- The largest Arcturus Therapeutics seller in Q4 2022 was Point72 Asset Management, an estimated $9.64M sold.
Based on aggregated 13F filings for Q4 2022.